Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US10610502 | METACEL PHARMS LLC | Oral baclofen solutions |
Aug, 2039
(15 years from now) |
Ozobax is owned by Metacel Pharms Llc.
Ozobax contains Baclofen.
Ozobax has a total of 1 drug patent out of which 0 drug patents have expired.
Ozobax was authorised for market use on 18 September, 2019.
Ozobax is available in solution;oral dosage forms.
Ozobax can be used as treatment of spasticity.
The generics of Ozobax are possible to be released after 30 August, 2039.
Drugs and Companies using BACLOFEN ingredient
Market Authorisation Date: 18 September, 2019
Treatment: Treatment of spasticity
Dosage: SOLUTION;ORAL